Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Late toxicity of image-guided hypofractionated radiotherapy for prostate: non-randomized comparison with conventional fractionation.
Jereczek-Fossa BA, Surgo A, Maisonneuve P, Maucieri A, Gerardi MA, Zerini D, Marvaso G, Ciardo D, Volpe S, Rojas DP, Riva G, Alessandro O, Dicuonzo S, Fanetti G, Romanelli P, Starzyńska A, Cattani F, Cambria R, Fodor C, Garibaldi C, Romanò C, De Cobelli O, Orecchia R. Jereczek-Fossa BA, et al. Among authors: maucieri a. Radiol Med. 2019 Jan;124(1):65-78. doi: 10.1007/s11547-018-0937-9. Epub 2018 Sep 15. Radiol Med. 2019. PMID: 30219945
Impact of image guidance on toxicity and tumour outcome in moderately hypofractionated external-beam radiotherapy for prostate cancer.
Jereczek-Fossa BA, Maucieri A, Marvaso G, Gandini S, Fodor C, Zerini D, Riva G, Alessandro O, Surgo A, Volpe S, Fanetti G, Arculeo S, Zerella MA, Parisi S, Maisonneuve P, Vavassori A, Cattani F, Cambria R, Garibaldi C, Starzyńska A, Musi G, De Cobelli O, Ferro M, Nolè F, Ciardo D, Orecchia R. Jereczek-Fossa BA, et al. Among authors: maucieri a. Med Oncol. 2018 Nov 27;36(1):9. doi: 10.1007/s12032-018-1233-1. Med Oncol. 2018. PMID: 30483899
Reporting combined outcomes with Trifecta and survival, continence, and potency (SCP) classification in 337 patients with prostate cancer treated with image-guided hypofractionated radiotherapy.
Jereczek-Fossa BA, Zerini D, Fodor C, Santoro L, Maucieri A, Gerardi MA, Vischioni B, Cambria R, Garibaldi C, Cattani F, Vavassori A, Matei DV, Musi G, De Cobelli O, Orecchia R. Jereczek-Fossa BA, et al. Among authors: maucieri a. BJU Int. 2014 Dec;114(6b):E3-E10. doi: 10.1111/bju.12530. Epub 2014 Feb 14. BJU Int. 2014. PMID: 24712723
Correction to: Late toxicity of image-guided hypofractionated radiotherapy for prostate: non-randomized comparison with conventional fractionation.
Jereczek-Fossa BA, Surgo A, Maisonneuve P, Maucieri A, Gerardi MA, Zerini D, Marvaso G, Ciardo D, Volpe S, Rojas DP, Riva G, Alessandro O, Dicuonzo S, Fanetti G, Romanelli P, Starzyńska A, Cattani F, Cambria R, Fodor C, Garibaldi C, Romanò C, De Cobelli O, Orecchia R. Jereczek-Fossa BA, et al. Among authors: maucieri a. Radiol Med. 2020 Jan;125(1):107. doi: 10.1007/s11547-019-01086-w. Radiol Med. 2020. PMID: 31591702
Salvage image-guided intensity modulated or stereotactic body reirradiation of local recurrence of prostate cancer.
Zerini D, Jereczek-Fossa BA, Fodor C, Bazzani F, Maucieri A, Ronchi S, Ferrario S, Colangione SP, Gerardi MA, Caputo M, Cecconi A, Gherardi F, Vavassori A, Comi S, Cambria R, Garibaldi C, Cattani F, De Cobelli O, Orecchia R. Zerini D, et al. Among authors: maucieri a. Br J Radiol. 2015 Aug;88(1052):20150197. doi: 10.1259/bjr.20150197. Epub 2015 Jun 9. Br J Radiol. 2015. PMID: 26055506 Free PMC article.
Present clinical practice of breast cancer radiotherapy in Italy: a nationwide survey by the Italian Society of Radiotherapy and Clinical Oncology (AIRO) Breast Group.
Gregucci F, Fozza A, Falivene S, Smaniotto D, Morra A, Daidone A, Barbara R, Ciabattoni A; Italian Society of Radiotherapy and Clinical Oncology (AIRO) Breast Group. Gregucci F, et al. Radiol Med. 2020 Jul;125(7):674-682. doi: 10.1007/s11547-020-01147-5. Epub 2020 Feb 20. Radiol Med. 2020. PMID: 32078120